SCHEMBL17120271

SCHEMBL17120271

CC1(C)OB(c2cccc(-c3ccc4ccc5c(-c6cccc7ccccc67)ccc6ccc3c4c65)c2)OC1(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LIPG Q9Y5X9 6/20 0.44
▸ LPL P06858 5/20 0.44
▸ CHRNA1 P02708 1/20 0.37
▸ CHRNG P07510 1/20 0.37
▸ CHRNB1 P11230 1/20 0.37
▸ CHRNB2 P17787 1/20 0.37
▸ SLC6A2 P23975 1/20 0.37
▸ CHRNB4 P30926 1/20 0.37
▸ SLC6A4 P31645 1/20 0.37
▸ CHRNA3 P32297 1/20 0.37
▸ CHRNA4 P43681 1/20 0.37
▸ SLC6A3 Q01959 1/20 0.37
▸ CHRND Q07001 1/20 0.37
▸ PRMT5 O14744 1/20 0.36
▸ WDR77 Q9BQA1 1/20 0.36
▸ MAOA P21397 2/20 0.36
▸ CYP1A2 P05177 2/20 0.36
▸ ERBB2 P04626 1/20 0.36
▸ FYN P06241 1/20 0.36
▸ ACHE P22303 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20598689 0.93 LIPG (0.43) LIPGLPLCHRNA1CHRNGCHRNB1
SCHEMBL25681082 0.93 LIPG (0.47) LIPGLPLCHRNA1CHRNGCHRNB1
SCHEMBL12424936 0.91 LIPG (0.46) LIPGLPLPRMT5WDR77MAOA
SCHEMBL30009533 0.91 LIPG (0.46) LIPGLPLPRMT5WDR77MAOA
SCHEMBL25681092 0.91 LIPG (0.48) LIPGLPLCHRNA1CHRNGCHRNB1
SCHEMBL2248070 0.90 LIPG (0.49) LIPGLPLCHRNA1CHRNGCHRNB1
SCHEMBL25681132 0.89 LIPG (0.44) LIPGLPLCHRNA1CHRNGCHRNB1
SCHEMBL17940734 0.88 LIPG (0.52) LIPGLPLPRMT5WDR77MAOA
SCHEMBL25681126 0.88 LIPG (0.51) LIPGLPLCHRNA1CHRNGCHRNB1
SCHEMBL25681121 0.88 LIPG (0.51) LIPGLPLCHRNA1CHRNGCHRNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9831443-B2 Condensed cyclic compound and organic light-emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-28 — — US disclosed
US-9831443-B2 Condensed cyclic compound and organic light-emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-28 — — US disclosed
US-20150270498-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-09-24 — — US disclosed
US-20150270498-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-09-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150270498-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME CRY1, CRY2, MCM4 LIPG 2118/4885LPL 2063/4885CHRNA1 3097/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback